top of page
Pipeline AIM Biologicals AEZS-150 AEZS-130 (Macimorelin) Macimorelin Dx
Therapeutic Development Pipeline
Diagnostic Pipeline

Sales of Macrilen® (macimorelin) are temporarily discontinued in the United States commercial market for the diagnosis of adult growth hormone deficiency ("AGHD"), until anticipated re-launch with an alternate commercialization partner. Aeterna has an ongoing effort to identify strategic development and commercialization partner.
Specialty Biopharmaceutical Company
Data delayed 15 minutes unless otherwise indicated
bottom of page